Precipio(US:PRPO)2026-03-30 21:34Financial Performance - Research and development expenses increased to $1.6 million in 2025 from $1.3 million in 2024, reflecting a growth of approximately 23.1%[91] Employee Development - As of March 9, 2026, Precipio employed a total of 61 full-time and 10 part-time employees, with 44 in laboratory and production roles[92] - The company emphasizes employee development, providing training and resources to enhance skills and career growth[94] - Precipio's competitive compensation programs aim to align employee incentives with both short-term and long-term performance[95] Innovation and Technology - The company has filed U.S. and European patent applications for its proprietary HemeScreen technology, reinforcing its commitment to innovation[113] Environmental Responsibility - Precipio published its Environmental, Social, and Governance (ESG) Report in February 2023, highlighting its commitment to responsible business practices[106] - The company actively reduces waste and explores sustainability initiatives to minimize its environmental footprint[108] Compliance and Ethics - Compliance with various privacy laws, including the California Consumer Privacy Act (CCPA), is a priority, impacting business operations and strategies[115] - The company has a robust Code of Business Conduct and Ethics, with training and an anonymous hotline for reporting concerns[99] Leadership - Precipio's executive team includes experienced leaders, such as the CEO and CFO, who bring over 20 years of industry experience[102][103] Regulatory Classification - The company is classified as a smaller reporting company under Rule 12b-2 of the Securities Exchange Act of 1934, thus not required to provide detailed market risk disclosures[397]